Shire Enters Supply Agreement

Article

Shire's United States subsidiary enters supply agreement for Adderall XR.

Shire reported that its subsidiary Shire US has entered into an agreement to supply an authorized generic version of its product Adderall XR.  Under the agreement, Sandoz will market an authorized generic version of Adderall XR beginning July 1, 2016.  From the Dec. 1, 2013 effective date of the agreement through the end of the agreement’s five-year term, Sandoz has agreed to exclusively sell the authorized generic version of Adderall XR supplied by Shire.

Shire will manufacture and supply Sandoz with all dosage strengths of the authorized generic product.  Sandoz will distribute the product in the US.  Shire will receive a royalty from Sandoz’s sales of the product.

Source: Shire

Recent Videos
Behind the Headlines, episode 7
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content